Applications in response to this NOSI must be submitted using the following target funding opportunity announcement or subsequent reissued equivalent.
- PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
- PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Administrative supplements proposed through PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) must be within the general scope of the research or training that is already supported. Eligible activity codes for applications to PA-18-591 are limited to the mechanisms listed in PA-18-591.
Eligible activity codes for applications proposed through PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements Clinical Trial Optional) are limited to the following mechanisms: P01; P30; P50; R00; R01; R33; R35; R37; U01; U19; U24; and U54.
To be eligible for an Urgent Competitive Revision or an Administrative Supplement through this NOSI and the respective FOA, the parent award on which the revision application is based must:
- be an active NCI award (i.e., not be in an extension period) at the time the revision/supplement is awarded
- have sufficient time (i.e., 1 year) left to complete the studies proposed after the revision/supplement has been awarded within the existing project period (including a planned no-cost extension).